Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasm Metastasis 32Multiple Myeloma 23Leukemia, Myeloid, Acute 23Lymphoma 17Colorectal Neoplasms 16Breast Neoplasms 14Pancreatic Neoplasms 12Myelodysplastic Syndromes 12Triple Negative Breast Neoplasms 10Sarcoma 9Prostatic Neoplasms 9Leukemia, Lymphocytic, Chronic, B-Cell 9Burkitt Lymphoma 9Ovarian Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, T-Cell 7Glioma 7Endometrial Neoplasms 7Neuroblastoma 6Melanoma 6Lymphoma, Non-Hodgkin 6Lung Neoplasms 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Myeloproliferative Disorders 5Lymphoma, Follicular 5Fallopian Tube Neoplasms 5Cholangiocarcinoma 5Central Nervous System Neoplasms 5

Interventions

Carboplatin 5Radiotherapy 4Radiation 3Radiotherapy, Conformal 2Platinum 2Pemetrexed 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cisplatin 2Bevacizumab 21,2-diaminocyclohexaneplatinum II citrate 2veliparib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1methoxyamine 1lazertinib 1durvalumab 1capmatinib 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Metformin 1Ipilimumab 1Granulocyte Colony-Stimulating Factor 1Gefitinib 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of Lung × Biopsy × 30 days × Clear all
NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡